Page last updated: 2024-11-05

2,4-thiazolidinedione and Hyperandrogenism

2,4-thiazolidinedione has been researched along with Hyperandrogenism in 1 studies

thiazolidine-2,4-dione: structure in first source
1,3-thiazolidine-2,4-dione : A thiazolidenedione carrying oxo substituents at positions 2 and 4.

Hyperandrogenism: A condition caused by the excessive secretion of ANDROGENS from the ADRENAL CORTEX; the OVARIES; or the TESTES. The clinical significance in males is negligible. In women, the common manifestations are HIRSUTISM and VIRILISM as seen in patients with POLYCYSTIC OVARY SYNDROME and ADRENOCORTICAL HYPERFUNCTION.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Taylor, AE1

Reviews

1 review available for 2,4-thiazolidinedione and Hyperandrogenism

ArticleYear
Insulin-lowering medications in polycystic ovary syndrome.
    Obstetrics and gynecology clinics of North America, 2000, Volume: 27, Issue:3

    Topics: Diazoxide; Female; Humans; Hyperandrogenism; Hyperinsulinism; Hypoglycemic Agents; Insulin Resistanc

2000